VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Ono Pharma Submits Supplemental Application in Japan to Expand OPDIVO® for Unresectable Anaplastic Thyroid Cancer
Ono Pharma Submits Supplemental Application in Japan to Expand OPDIVO® for Unresectable Anaplastic Thyroid Cancer
Jun 11, 2026 12:09 CST Updated 12:19
Share:
